Uncategorized
How to use data to create better cannabis products for patients
Since 2018, Business of Cannabis has produced Medical Cannabis Week to surface and celebrate insights and innovations from patients, practitioners and the industry.
strainprint
19stories
17 Novlast updated
More in strainprint
- Cannabis + Technology
Michelle Arbus, VP of Research, Strainprint Technologies
Michelle Arbus is the VP/Research at Strainprint Technologies. As such, she oversees research products and helps understand, both from a patient and researcher perspective, how, when, why and what patients are using to treat conditions and indications. Strainprint is a partner for Cannabis + Technology on September 27, 2019 in Toronto.
- Cannabis + Technology
Michelle Arbus, Strainprint Technologies
Michelle Arbus heads up research at Strainprint. She joined BofC Live to provide updates about their research project regarding the use of medical cannabis to treat endometriosis.
- Events
Medical Cannabis Talks
Launched in 2018, Medical Cannabis Week was imagined as a way to connect patients, practitioners and industry in dialogue about the future of medical cannabis.
- Your #1 Podcast on Cannabis News
Andrew Muroff, Strainprint
Business of Cannabis was streaming live from the O’Cannabiz Industry Awards Gala on Thursday evening, Apr. 25.
- Your #1 Podcast on Cannabis News
Jessica Moran, Strainprint
Business of Cannabis was streaming live from the O’Cannabiz Industry Awards Gala on Thursday evening, Apr. 25.
- Your #1 Podcast on Cannabis News
Ed Collins, CCI + Stephanie Karasick, Strainprint
BofC Live Mar. 18, 2019 | Cannabis goes to Europe – Ed Collins, CCI + Stephanie Karasick, Strainprint leads with kindness
- Your #1 Podcast on Cannabis News
Canadian Cannabis Awards | Noah Kauffman, Strainprint
Noah Kauffman, Strainprint
- Your #1 Podcast on Cannabis News
Quick Hits with Michelle Arbus, Strainprint & Dr. Prutchi Sagiv, Gynica
Last week, Strainprint, a leader in cannabis data and analytics, announced a partnership with Israeli research leaders, Lumir Lab and Gynica to conduct the world’s first international clinical study on the use of cannabis to treat endometriosis.
